Back to Clinical Trials

Brief Title: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

IIT2020-13-GRESHAM-ELLY: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

INTRODUCTION

  • Org Study ID: IIT2020-13-GRESHAM-ELLY
  • Secondary ID: N/A
  • NTC ID: NCT04604158
  • Sponsor: Gillian Gresham

BRIEF SUMMARY

This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.

  • Overall Status
    Recruiting
  • Start Date
    December 2, 2020
  • Phase
    Not Applicable
  • Study Type
    Interventional

PRIMARY OUTCOMES

Primary Outcome 1 - Measure: Absolute change in patient-reported anxiety scores at Day 30 compared with baseline.

Primary Outcome 1 - Timeframe: 30 days

CONDITION

  • Cancer
  • Cancer Metastatic
  • Neoplasms
  • Breast Cancer
  • Lung Cancer
  • Glioblastoma
  • Prostate Cancer
  • Gynecologic Cancer
  • Colorectal Cancer
  • Sarcoma
  • Kidney Cancer
  • Bladder Cancer
  • Lymphoma
  • Leukemia
  • Head and Neck Cancer
  • Pancreas Cancer
  • Multiple Myeloma
  • Anxiety
  • Social Isolation
  • Stress
  • Loneliness
  • Melanoma
  • Uterine Cancer

ELIGIBILITY

Inclusion Criteria:
Diagnosis of cancer of any type and currently receiving cancer-targeted treatment or have received cancer-targeted treatment within 6 months of consent date based on self-report. Cancer-targeted treatment includes chemotherapy, radiation therapy, hormonal therapy, biologic therapy, immunotherapy, and surgery.

- 18 years or older

- Access to and ability to use an iPhone (SE+, iOS 12.4+)

- Ability to understand and read English

- Have an understanding, ability, and willingness to fully comply with study procedures and restrictions
Exclusion Criteria:
- Hearing loss or vision impairment that would preclude the participant from accessing and using the app (use of hearing aids or visual aids is acceptable) based on self-report.

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: Gillian Gresham, PhD

Role: Principal Investigator

Affiliation: Cedars-Sinai Medical Center

Overall Contact

Name: Gillian Gresham, PhD

Phone: 310-423-3341

Email: gillian.gresham@cshs.org

LOCATION

Facility Status Contact
Facility: Cedars Sinai Medical Center
Los Angeles, California 90048
United States
Status: Recruiting Contact: Contact
Gillian Gresham
310-423-3341
gillian.gresham@cshs.org